1 |
Bae D, Lee JY, Ha N, Park J, Baek J, Suh D, Lim HS, Ko SM, Kim T, Som Jeong D, Son WC. CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis. Sci Rep 2021;11:14466. [PMID: 34262061 DOI: 10.1038/s41598-021-93232-6] [Reference Citation Analysis]
|
2 |
Li M, Hu W, Wang R, Li Z, Yu Y, Zhuo Y, Zhang Y, Wang Z, Qiu Y, Chen K, Ding Q, Qi W, Zhu M, Zhu Y. Sp1 S-Sulfhydration Induced by Hydrogen Sulfide Inhibits Inflammation via HDAC6/MyD88/NF-κB Signaling Pathway in Adjuvant-Induced Arthritis. Antioxidants 2022;11:732. [DOI: 10.3390/antiox11040732] [Reference Citation Analysis]
|
3 |
Fang TJ, Lin CH, Lin YZ, Chiu MH, Li RN, Chan HC, Yeh YT, Yen JH. Lower HDAC6 mRNA expression and promoter hypomethylation are associated with RA susceptibility. J Formos Med Assoc 2021:S0929-6646(21)00480-0. [PMID: 34732304 DOI: 10.1016/j.jfma.2021.10.008] [Reference Citation Analysis]
|